financetom
Business
financetom
/
Business
/
Toymaker Mattel's quarterly loss smaller than expected as cost cuts pay off
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Toymaker Mattel's quarterly loss smaller than expected as cost cuts pay off
Apr 23, 2024 1:23 PM

*

Reaffirms full-year sales and profit forecasts

*

CEO says "off to a good start for the year"

*

MAT posts Q1 adj loss of 5 cents/shr vs est. of 12

cents/shr

*

Reports Q1 sales of $809.5 mln vs est. of $831.8 mln

By Granth Vanaik

April 23 (Reuters) - Mattel ( MAT ) posted a

smaller-than-expected loss for the first quarter on Tuesday,

helped by the Barbie maker's tight leash on costs while demand

remains tepid for its toys and games.

The toymaker has planned to exit less profitable brands,

consolidated its American Girl operating segment and streamlined

its supply chain as part of efforts to achieve $200 million in

savings by 2026.

"We are off to a good start for the year with significant

margin expansion and very strong improvement in free cash flow,"

CEO Ynon Kreiz said in an interview with Reuters.

Mattel's ( MAT ) gross margin grew 8 percentage points to 48% in the

first quarter, also in part due to easing input costs as well as

lower inventory management expenses.

Rival Hasbro ( HAS ), which is expecting a bigger hit to

revenue in the first half of 2024, has also undertaken workforce

reductions to trim costs. It is set to report its first-quarter

results on Wednesday.

Mattel's ( MAT ) first-quarter sales of $809.5 million missed

estimates of $831.8 million. The company posted an adjusted loss

of 5 cents per share, compared with estimates of 12 cents,

according to LSEG data.

The company, which reaffirmed its full-year sales and profit

forecasts, said in February it expected the toy industry to

decline in 2024 but at a slower rate than 2023.

Kreiz said on Tuesday while sales declined, consumer demand

trends were improving during the quarter.

Net sales in its North American segment rose by 2% on a

constant currency basis, compared to a 27% drop a year earlier.

Worldwide gross billings for Barbie, Mattel's ( MAT ) biggest brand,

rose 0.3% in the quarter, while Hot Wheels' billings rose 5%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Spacex Targets More Than $2 Trillion Valuation In IPO - Bloomberg News
BRIEF-Spacex Targets More Than $2 Trillion Valuation In IPO - Bloomberg News
Apr 2, 2026
April 2 (Reuters) - * SPACEX TARGETS MORE THAN $2 TRILLION VALUATION IN IPO - BLOOMBERG NEWS Source text: https://tinyurl.com/24kuseh2 ...
NFI Group Appoints Rob Marion as President of Motor Coach Industries
NFI Group Appoints Rob Marion as President of Motor Coach Industries
Apr 2, 2026
03:55 PM EDT, 04/02/2026 (MT Newswires) -- NFI Group ( NFYEF ) on said Rob Marion will serve as president of the company's Motor Coach Industries (MCI) unit. The bus and coach manufacturer said Marion will start his new role immediately, reporting directly to NFI's chief executive, John Sapp. NFI's former CEO, Paul Soubry, had served as interim president of...
Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
Apr 2, 2026
– Enbumyst, First and Only FDA-Approved Nasal Spray Loop Diuretic Now Integrated into Esperion’s Cardiovascular Franchise, Anticipated to Drive Portfolio Expansion, Commercial Leverage, and Continued Revenue Growth – ANN ARBOR, Mich., April 02, 2026 (GLOBE NEWSWIRE) -- Esperion (the Company) today announced the closing of its acquisition of Corstasis Therapeutics Inc., a privately-held, commercial-stage biopharmaceutical company advancing innovative outpatient therapies for...
Cresco Labs Secures Conditional Texas Medical Cannabis License
Cresco Labs Secures Conditional Texas Medical Cannabis License
Apr 2, 2026
03:57 PM EDT, 04/02/2026 (MT Newswires) -- Cresco Labs ( CRLBF ) said Thursday afternoon it was conditionally awarded a license under the Texas Compassionate Use Program, allowing it to cultivate, process, and dispense medical cannabis. The company said the license supports its state-by-state expansion strategy, with Texas being one of the largest markets in the United States. Winning a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved